Johnson & Johnson (JNJ) Stock Despite currency headwinds and higher costs, JNJ topped analysts’ Q3 expectations . JNJ’s Q3 revenue increased 1.9% to $23.8 billion, while adjusted EPS declined ...We believe that Pfizer stock (NYSE: PFE) is currently a better pick than its peer, Johnson & Johnson stock (NYSE: JNJ), given its relatively lower valuation of 3.1x trailing revenues, compared to ...Nov 7, 2022 · The Street’s Moderate Buy consensus rating on Johnson & Johnson stock is based on four Buys and seven Holds. At $181.60, the average JNJ stock price prediction suggests 5% upside potential. NYSE: JNJ Johnson & Johnson. Market Cap. $381B. Today's Change (2.40%) $3.72. Current Price. $158.38. ... Although it can be useful when comparing two similar companies, market capitalization and ...New Brunswick, N.J. (January 26, 2021) – Johnson & Johnson(NYSE: JNJ) today announced results for fourth-quarter and full year 2020. “Our notable full year performance reflects the continued confidence from patients, physicians, customers and consumers in our life-enhancing products and medicines, particularly throughout theJohnson & Johnson (NYSE:JNJ) CFO Joseph Wolk and pharmaceuticals division head Jennifer Taubert are reportedly leading contenders for the CEO job in the …JNJ's 3.2% dividend yield clocks in at double the 1.5% yield of the S&P 500 ( SP500 ). The company's 47% EPS payout ratio comes in meaningfully below the 60% EPS payout ratio that is considered ...As such, its total long-term debt to capitalization ratio is also higher at 36.9% Vs. J&J’s 27.6%. J&J’s interest coverage in the trailing 12 months is 25.69x, much better than Pfizer’s 9 ...Oct 31, 2023 · Stelara's total sales were $2,864 million in Q3 2023, an increase of 16.9% year-over-year. The company's management raised its financial guidance for full-year 2023 adjusted-diluted EPS from $10 ... BioNTech SE ADR. -1.01%. $23.63B. ABBV | Complete AbbVie Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.We all know Johnson & Johnson (JNJ 1.11%) thanks to top consumer products like Band-Aid bandages and the company's script logo. But times are changing. J&J recently spun off its consumer health ...Apr 17, 2023 · Johnson & Johnson (NYSE:JNJ) is the largest by market cap valuation of what I tend to refer to as the "Big 8" U.S. Pharmas - although perhaps not for much longer. In this article, we will take a closer look at Johnson & Johnson (NYSE:JNJ) and Pfizer , the two largest US-based pharmaceutical companies by market capitalization. Both are high-quality dividend ...14,305.03 +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Johnson & Johnson (JNJ) NYSE - …May 9, 2023 · ABBV has an FY1 P/E ratio of 13.49x, compared to JNJ’s 15.27x. As a result, ABBV's PEG ratio turns out to be 1.55x and JNJ's 2.57x, both higher than the preferred threshold of 1x that Lynch ... Johnson & Johnson ( NYSE: JNJ) on Monday gave more details about its previously announced plans to split off shares of consumer health unit Kenvue ( NYSE: KVUE) through an exchange offer to ...Jan 24, 2023 · NEW BRUNSWICK, N.J. – January 24, 2023 – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2022. “Our full year 2022 results reflect the continued strength and stability of our three business segments, despite macroeconomic challenges,” said Joaquin Duato, Chairman of the Board and Chief Executive Officer. Relative Read of JNJ vs SPX 500. JNJ vs SPX500 Technical Analysis (TradingView, Author's Analysis) On the relative chart of JNJ / S&P 500 , I see sharp moves being made by the sellers. I ...Johnson & Johnson MedTech Acquires Laminar, Inc. NEW BRUNSWICK, N.J., November 30, 2023--Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc., a privately ...Kenvue ( NYSE: KVUE ), the former consumer health division of Johnson & Johnson ( JNJ ), will join the S&P 500 once J&J completes an exchange offer of Kenvue ( KVUE) shares it owns. J&J ( JNJ) has ...In such a scenario, you can compute the average annual return over these ten years (CAGR) using the formula provided below: R = 100 x [ (EP/SP)^1/10 - 1] where, EP - JNJ price on November 24, 2023 = …Aug 29, 2016 · Using the JNJ investor calculator here, $10,000 investment in JNJ would be valued at $40,028.63 with dividend reinvested. Again, using the same calculator to compute the S&P500 return in the ... Galeanu Mihai/iStock via Getty Images. Thesis. I first wrote about AbbVie Inc. (NYSE:ABBV) back in Aug 2021.At that time, the stock was trading at $114 per share, or only about 8x times its ...JNJ's best-in-class "A+" profitability grade provides robust support in a high-interest rate environment. Its renewed focus on its pharma and medtech business provides further valuation support.Johnson & Johnson (NYSE:JNJ) pays an annual dividend of $4.76 per share and currently has a dividend yield of 3.12%. The company has been increasing its dividend for 61 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 35.34%.Apr 17, 2023 · Johnson & Johnson will report its Q1 results on April 18 before market open. Read what to expect from JNJ stock in terms of earnings and talc litigation. ... (NYSE:JNJ) in January, when I compared ... २०२३ फेब्रुअरी १० ... Which stocks to buy in this stock comparison grudge match?! Coca-Cola vs Pepsi, Deere vs Caterpillar, JNJ vs Merck! Must Watch!Kenvue (NYSE:KVUE) has filed to raise an estimated $5 billion in an IPO of its common stock, according to an S-1 registration statement. ... (NYSE:JNJ) as part of its separation process.JNJ - Johnson & Johnson. NYSE - Nasdaq Real Time Price. Currency in USD. Follow.2. $JNJ - almost time to enter Looking at the chart dating back 5 years for NYSE:JNJ , there is a decent entry point around $150. Looking for a slight drop in current price to enter. Entry point will follow along the 5 year …Johnson & Johnson (JNJ) Stock Despite currency headwinds and higher costs, JNJ topped analysts’ Q3 expectations . JNJ’s Q3 revenue increased 1.9% to $23.8 billion, while adjusted EPS declined ...Get the latest Johnson & Johnson (JNJ) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 14,305.03 +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Johnson & Johnson (JNJ) NYSE - NYSE Delayed Price....२०२३ जनवरी १७ ... Our JNJ stock analysis and review look at why Johnson and Johnson stock might be the best stock to own if you could only hold one.Johnson & Johnson and AbbVie Inc. historically fall 70% to 80% less than the S&P 500 Index during bear markets since 1985. Both are great SWAN choices, but one is the far better long-term investment.14,305.03 +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Johnson & Johnson (JNJ) NYSE - …We believe that Pfizer stock (NYSE: PFE) is currently a better pick than its peer, Johnson & Johnson stock (NYSE: JNJ), given its relatively lower valuation of 3.1x trailing revenues, compared to ...JNJ Earnings Date and Information. Johnson & Johnson last announced its quarterly earnings data on October 17th, 2023. The reported $2.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.52 by $0.14. The business had revenue of $21.35 billion for the quarter, compared to analysts' …Growth Stocks. Nvidia stock fell 2.85% on Thursday to 467.70, undercutting the 476.09 double-bottom buy point. Meta stock fell 1.5% to 327.15, but recovered to …NYSE: JNJ Johnson & Johnson. Market Cap. $372B. Today's Change (0.74%) $1.14. ... Johnson & Johnson (JNJ 0.74%) and AbbVie (ABBV 0.35%) are two of the bigger names in healthcare stocks. The ...Stock analysis for Johnson & Johnson (JNJ:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.As a comparison, stalwart Johnson & Johnson (NYSE:JNJ) has a roughly 3% dividend, a P/E of 19.6, a Beta of about 1, and analysts' average five-year EPS growth estimate per annum of +5.44%. DLR ...New Brunswick, N.J. (January 26, 2021) – Johnson & Johnson(NYSE: JNJ) today announced results for fourth-quarter and full year 2020. “Our notable full year performance reflects the continued confidence from patients, physicians, customers and consumers in our life-enhancing products and medicines, particularly throughout theFeb 7, 2023 · While Coca-cola saw its sales rise at an average annual growth rate of 4.8% to $38.7 billion in 2021, vs. $34.3 billion in 2018, J&J’s saw its revenue grow at an average rate of 5.1% to $94.9 ... Comparatively, 71.3% of Beyond shares are owned by institutional investors. 50.9% of Onion Global shares are owned by company insiders. Comparatively, 1.3% of …It grew by an impressive 22% year over year to $986 million in the most recent reported first quarter. Total revenue for the quarter rose by 14% to $1.7 billion from the year-ago period. Since the ...In Brief. Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company ...NEW BRUNSWICK, N.J., July 1, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.In addition, the data showed that the …While both Johnson & Johnson (NYSE:JNJ) and Medtronic (NYSE:MDT) are good companies, ... Hard to compare with JNJ, because MDT is med tech and JNJ is med tech + pharma + consumer goods.NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2023. “Johnson & Johnson delivered strong results and significant pipeline advances in the third quarter, providing a solid foundation for future sustained growth,” said Joaquin Duato, Chairman of the Board and Chief Executive Officer.... to newsletters. Sign In. PROFILE. Johnson & Johnson. NYSE: JNJ. New Brunswick, New Jersey. $158.38. +3.72 (+2.40%). Share Price. as of December 1 4:00:00 PM EST.Jan 24, 2023 · NEW BRUNSWICK, N.J. – January 24, 2023 – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2022. “Our full year 2022 results reflect the continued strength and stability of our three business segments, despite macroeconomic challenges,” said Joaquin Duato, Chairman of the Board and Chief Executive Officer. NEW BRUNSWICK, N.J., MARCH 8, 2023 – Johnson & Johnson (NYSE: JNJ) today announced that Kenvue Inc. (“Kenvue”), a wholly owned subsidiary of Johnson & Johnson, priced an offering of the following series of senior unsecured notes in an aggregate principal amount of $7.75 billion (each series of notes collectively, the “Notes ...Potentially undervalued companies in the Pharmaceuticals & Biotech industry. Research Johnson & Johnson's (NYSE:JNJ) stock key valuation metrics while comparing it with …View the latest Johnson & Johnson (JNJ) stock price, news, historical charts, analyst ratings and financial information from WSJ.This article considers Johnson & Johnson (NYSE:JNJ) in that context. We will review wealth-building goals, identify company activities to drive future results, and …JHVEPhoto/iStock Editorial via Getty Images. The Janssen Pharmaceutical unit of Johnson & Johnson ( NYSE: JNJ) announced Thursday that the U.S. FDA granted accelerated approval for its bispecific ...The current consensus for Johnson & Johnson ( JNJ) implies $10.75 EPS on $100.21B in revenue. JNJ intends to report a ~$20B gain in Q3 2023 in relation to the Kenvue separation and plans to ...The two companies I'll be discussing in this article are longtime dividend payers in the consumer and healthcare industries. Both Procter & Gamble ( PG 0.94%) and Johnson & Johnson ( JNJ -0.20% ...Stock analysis for Johnson & Johnson (JNJ:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Summary. JNJ is expected to report revenues of $23.87 billion and an EPS of $2.56 in its upcoming second quarter earnings report on July 19. The company has reported a positive earnings surprise ...Relative Read of JNJ vs SPX 500. JNJ vs SPX500 Technical Analysis (TradingView, Author's Analysis) On the relative chart of JNJ / S&P 500 , I see sharp moves being made by the sellers. I ...The PE ratio of Johnson & Johnson has averaged 45.3 over the last ten years. The current P/E ratio of 11.12 is 75% lower than the historical average. Looking back at the last ten years, JNJ's PE ratio peaked in the Dec 2017 quarter at 291.08, when the price was $139.72 and the EPS was $0.48. The lowest point was in the Oct 2023 quarter, when it ...Sundry Photography/iStock Editorial via Getty Images. Johnson & Johnson ( NYSE: JNJ) said Monday that its previously announced offer to shareholders to exchange their shares of JNJ common stock ...Apr 17, 2023 · Johnson & Johnson (NYSE:JNJ) Johnson & Johnson is a blue-chip stock that’s been dealing with a major legal overhang for over a decade. Because that overhang could be nearing its end and given ... Eli Lilly leapfrogged Johnson & Johnson (NYSE:JNJ) in market cap for the first time. Just a few years ago, the latter was upwards of $250 billion more highly valued than the former. But with major ...14,305.03 +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Johnson & Johnson (JNJ) NYSE - NYSE Delayed Price....JNJ New York Stock Exchange • delayed by 15 minutes • CURRENCY IN USD • Pharmaceuticals. JOHNSON & JOHNSON (JNJ) ... Quick compare. Day Range. 145.64 148.50. Open 148.25. 52 Week Range.Get the latest Pfizer Inc. (PFE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.NEW BRUNSWICK, N.J., July 24, 2023 -- Johnson & Johnson (NYSE: JNJ) today announced its intention to split-off at least 80.1% of the shares of Kenvue Inc. (NYSE: KVUE) (“Kenvue”) through an exchange offer. Kenvue, formerly Johnson & Johnson ’s Consumer Health business, completed its initial public offering (“IPO”) in May 2023.For the full year, Johnson & Johnson (NYSE:JNJ) posted an EPS of $10.15, a 4% jump from the comparable period last year. As of the end of the third quarter of 2022, 85 hedge funds had stakes in ...Sep 25, 2017 · As such, its total long-term debt to capitalization ratio is also higher at 36.9% Vs. J&J’s 27.6%. J&J’s interest coverage in the trailing 12 months is 25.69x, much better than Pfizer’s 9 ... This article considers Johnson & Johnson (NYSE:JNJ) in that context. We will review wealth-building goals, identify company activities to drive future results, and …Relative valuation technique determine the value of Johnson & Johnson by comparing it to similar entities (like industry or sector) on the basis of several relative ratios that compare its stock price to relevant variables that affect the stock value, such as earnings, book value, and sales. Current Valuation Ratios.New Brunswick, N.J. (January 26, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2020.“Our notable full year performance reflects the continued confidence from patients, physicians, customers and consumers in our life-enhancing products and medicines, particularly throughout the …Justin Sullivan/Getty Images News. Johnson & Johnson ( JNJ) said Thursday that it could launch an exchange offer for its stake in recently spun-out Kenvue ( NYSE: KVUE) "as early as the coming ...Johnson & Johnson (NYSE:JNJ) Johnson & Johnson. 158.39. Delayed Data. As of 4:00pm ET. +3.73 / +2.41%. Today’s Change. 144.95.NEW BRUNSWICK, N.J., July 1, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.In addition, the data showed that the …NVIDIA Corporation Common Stock. $450.47 +0.42 +0.09%. MSFT. Microsoft Corporation Common Stock. $352.60 -0.20 -0.06%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours ...Johnson & Johnson : Historical stock chart comparison, Stock Johnson & Johnson | JNJ | US4781601046 | Nyse.Nyse jnj compare, vtbix, how much is a 1976 quarter dollar worth
Discover historical prices for JNJ stock on Yahoo Finance. View daily, weekly or monthly format back to when Johnson & Johnson stock was issued. ... NYSE - NYSE Delayed Price. Currency in USD .... Nyse jnj compare
total bondRevenue Growth. Between 2017 and 2020, Merck’s revenues grew by about 13%, from around $42.3 billion to $48.0 billion, primarily led by its oncology drug – Keytruda – which saw its sales ...Research Johnson & Johnson's (NYSE:JNJ) stock key valuation metrics while comparing it with its industry peers & market side by side.Apr 4, 2023 · JNJ Q4/22 Presentation. “Pharmaceuticals” – the most important segment for Johnson & Johnson, which is responsible for more than half of revenue – increased sales 1.7% YoY from $51,680 ... This article considers Johnson & Johnson (NYSE:JNJ) in that context. We will review wealth-building goals, identify company activities to drive future results, and …As a comparison, stalwart Johnson & Johnson (NYSE:JNJ) has a roughly 3% dividend, a P/E of 19.6, a Beta of about 1, and analysts' average five-year EPS growth estimate per annum of +5.44%. DLR ...Johnson & Johnson MedTech Acquires Laminar, Inc. NEW BRUNSWICK, N.J., November 30, 2023--Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc., a privately ...Sep 28, 2022 · J&J’s revenue growth of 7.2% over the last twelve months is much better than -1.7% for Medtronic. Even if we look at a longer time frame, J&J’s sales growth has been better. It rose at an ... Eli Lilly leapfrogged Johnson & Johnson (NYSE:JNJ) in market cap for the first time. Just a few years ago, the latter was upwards of $250 billion more highly valued than the former. But with major ...Justin Sullivan/Getty Images News. Johnson & Johnson ( JNJ) said Thursday that it could launch an exchange offer for its stake in recently spun-out Kenvue ( NYSE: KVUE) "as early as the coming ...Research Pfizer's (NYSE:PFE) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... NYSE:JNJ US$381.3b. Price History & Performance. Summary of all time highs, changes and price drops for Pfizer; Historical stock prices; Current Share Price: US$28.91: 52 Week High:Stock analysis for Johnson & Johnson (JNJ:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Johnson & Johnson (NYSE: JNJ) has a higher price-to-earnings ratio of 28.61x compared to its average ratio,, and the 36-month beta value for JNJ is at 0.56. Analysts have varying views on the stock, with 7 analysts rating it as a “buy,” 2 rating it as “overweight,” 14 as “hold,” and 0 as “sell.”. The electric vehicle boom is ...Research Pfizer's (NYSE:PFE) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... NYSE:JNJ US$381.3b. Price History & Performance. Summary of all time highs, changes and price drops for Pfizer; Historical stock prices; Current Share Price: US$28.91: 52 Week High:The race for Johnson & Johnson's (NYSE: JNJ) top executive position has intensified following the unexpected exit of Ashley McEvoy, the former head of the company's medical device unit ...The 5-year average annualized dividend growth rate of Johnson & Johnson is 5.75%. The largest dividend yield was 3.79% on May 24, 2012. Based on the trailing twelve months, the year-over-year ...The two companies I'll be discussing in this article are longtime dividend payers in the consumer and healthcare industries. Both Procter & Gamble ( PG 0.94%) and Johnson & Johnson ( JNJ -0.20% ...JNJ Similar Stocks Comparison ; ABBV · AMGN · AMRN ; Abbvie · Amgen · Amarin PLC - American Depositary Shares Each Representing One Ordinary Share ; 138.50 · 266.60 ...JNJ New York Stock Exchange • delayed by 15 minutes • CURRENCY IN USD • Pharmaceuticals. JOHNSON & JOHNSON (JNJ) ... Quick compare. Day Range. 145.64 148.50. Open 148.25. 52 Week Range.A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. Johnson & Johnson debt to capital ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022 not reaching 2020 level. Debt to capital ratio (including operating lease liability) A solvency ratio calculated as total debt (including ...Johnson & Johnson has a total shareholder equity of $71.2B and total debt of $29.9B, which brings its debt-to-equity ratio to 42%. Its total assets and total liabilities are $166.1B and $94.8B respectively. Johnson & Johnson's EBIT is $27.6B making its interest coverage ratio -78. It has cash and short-term investments of $23.5B.Johnson & Johnson has an annual dividend of $4.76 per share, with a forward yield of 3.01%. The dividend is paid every three months and the last ex-dividend date was Nov 20, 2023. Dividend Yield. 3.01%. Annual Dividend.Find real-time JNJ - Johnson & Johnson stock quotes, company profile, news and forecasts from CNN Business.NYSE: JNJ. Johnson & Johnson. Today's Change. (2.40%) $3.72. Current Price ... What is the Difference Between Simple & Compound Interest? A person looking at a ...42.65. 33.08. Compare Johnson & Johnson (JNJ) to other companies with price, technicals, performance, and fundamentals comparison. २०२३ जुलाई २४ ... NEW BRUNSWICK, N.J., July 24, 2023 -- Johnson & Johnson (NYSE: JNJ) today announced its intention to split-off at least 80.1% of the shares of ...Relative valuation technique determine the value of Johnson & Johnson by comparing it to similar entities (like industry or sector) on the basis of several relative ratios that compare its stock price to relevant variables that affect the stock value, such as earnings, book value, and sales. Current Valuation Ratios.By 2023-end, Johnson & Johnson will spin off its Consumer Health segment. JNJ pays a consistent and growing dividend. Click for our take on JNJ stock.Find real-time JNJ - Johnson & Johnson stock quotes, company profile, news and forecasts from CNN Business.NYSE: JNJ. New Brunswick, New Jersey. $158.38 +3.72 (+2.40%) Share Price. as of December 1 4:00:00 PM EST. About Johnson & Johnson. Johnson & Johnson is a holding company, which engages in the ... Overview Stock Screener Earnings Calendar Sectors NYSE | JNJ U.S.: NYSE Johnson & Johnson Watch list Set a price target alert After Hours Last Updated: Nov 29, 2023 7:16 …2. Johnson & Johnson (NYSE: JNJ) On the other end of the scale, Johnson & Johnson is one of the grand old names of American health care services. Founded in 1886, it’s one of the biggest ...Ratios. Price/Earnings ttm. 14.41. 42.65. 33.08. Compare Johnson & Johnson (JNJ) to other companies with price, technicals, performance, and fundamentals comparison.Real time Johnson & Johnson (JNJ) stock price quote, stock graph, news & analysis.Dec 1, 2023 · On Friday, Johnson & Johnson (JNJ:NYQ) closed at 158.38, 9.27% above its 52-week low of 144.95, set on Oct 27, 2023. Data delayed at least 15 minutes, as of Dec 01 2023 21:10 GMT. Latest Johnson & Johnson (JNJ:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. We believe that Abbott stock (NYSE: ABT) is a better pick than its sector peer, Johnson & Johnson stock (NYSE: JNJ). Both stocks are trading at a similar valuation of a little over 4x trailing ...Johnson & Johnson Stock Price, News & Analysis (NYSE:JNJ) $154.56 +2.45 (+1.61%) (As of 12:45 PM ET) Compare Today's Range $151.92 $154.58 50-Day Range $145.62 $161.66 52-Week Range $144.95 $181.04 Volume 2.76 million shs Average Volume 11.49 million shs Market Capitalization $372.07 billion P/E Ratio 11.47 Dividend Yield 3.08% Price TargetJan 24, 2023 · NEW BRUNSWICK, N.J., January 24, 2023--Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2022. "Our full year 2022 results reflect the continued strength and ... Stock Price Forecast. According to 15 stock analysts, the average 12-month stock price forecast for JNJ stock stock is $169.07, which predicts an increase of 6.75%. The lowest target is $40 and the highest is $215. …Johnson & Johnson ( NYSE: JNJ) is a legendary healthcare company with a renewed focus on its pharmaceutical and medtech segments, making it an excellent defensive pick. The recent selloff in JNJ ...The two companies I'll be discussing in this article are longtime dividend payers in the consumer and healthcare industries. Both Procter & Gamble ( PG 0.94%) and Johnson & Johnson ( JNJ -0.20% ...J&J stock price quote (NYSE: JNJ), historical charts, related news, ... Price vs Fair Value . View History JNJ is trading at a 3% discount. Price $158.37. Dec 1, 2023.For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. Compare JNJ With Other Stocks. Johnson & Johnson ...Annual Growth Forecast - ABT vs. JNJ. Trefis. 2. J&J And Abbott Have Similar Margins. J&J’s operating margin of 23.9% over the last twelve months is in line with 23.6% for Abbott.Nov 29, 2023 · Well-diversified drug pipeline with 52 drugs in late-stage approval - a good hedge for its patent expirations Kenv... 6.3% Undervalued US$169.00 Current price US$158.4 20% Undervalued About Right 20% Overvalued. Price at publication US$160.26. View narrative. Using the JNJ investor calculator here, $10,000 investment in JNJ would be valued at $40,028.63 with dividend reinvested. Again, using the same calculator to compute the S&P500 return in the ...२०२० अप्रिल २४ ... ... JNJ stock to see which Dividend Aristocrat companies is the best ... Stock Market Crash https://youtu.be/2ZYpSIwCKWc.JNJ's 3.2% dividend yield clocks in at double the 1.5% yield of the S&P 500 ( SP500 ). The company's 47% EPS payout ratio comes in meaningfully below the 60% EPS payout ratio that is considered ...This is a decrease of -17% compared to the previous 30 days. MarketBeat Follows. Only 40 people have added Johnson & Johnson to their MarketBeat watchlist in ...Relative valuation technique determine the value of Johnson & Johnson by comparing it to similar entities (like industry or sector) on the basis of several ...74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Johnson & Johnson (JNJ) NYSE - NYSE Delayed Price. Currency in USD Follow 2W 10W 9M 158.38 +3.72 (+2.41%) At close: 04:00PM EST. Otcmkts nrsaf, best dental insurance in louisiana